Viewing Study NCT05983133


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2026-03-10 @ 7:27 PM
Study NCT ID: NCT05983133
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2023-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module